PFKFB3-mediated glycometabolism reprogramming modulates endothelial differentiation and angiogenic capacity of placenta-derived mesenchymal stem cells

PFKFB3-mediated glycometabolism reprogramming modulates endothelial differentiation and angiogenic capacity of placenta-derived mesenchymal stem cells

Abstract Background Mesenchymal stem cells (MSCs) have a great potential ability for endothelial differentiation, contributing to an effective means of therapeutic angiogenesis. Placenta-derived mesenchymal stem cells (PMSCs) have gradually attracted attention, while the endothelial differentiation...

Full description

Bibliographic Details
Main Authors:	Yang Zhang, Yanqi Zhong, Weifang Liu, Fanghui Zheng, Yin Zhao, Li Zou, Xiaoxia Liu
Format:	Article
Language:	English
Published:	BMC 2022-08-01
Series:	Stem Cell Research & Therapy
Subjects:	Mesenchymal stem cells Placenta Endothelial differentiation Glycometabolism reprogramming Glycolysis PFKFB3
Online Access:	https://doi.org/10.1186/s13287-022-03089-3

Similar Items

Placenta-Targeted Nanoparticles Loaded with PFKFB3 Overexpression Plasmids Enhance Angiogenesis and Placental Function
by: Qi Li, et al.
Published: (2022-11-01)

Canonical and Non-Canonical Roles of PFKFB3 in Brain Tumors
by: Reinier Alvarez, et al.
Published: (2021-10-01)

MALAT1 sponges miR-26a and miR-26b to regulate endothelial cell angiogenesis via PFKFB3-driven glycolysis in early-onset preeclampsia
by: Qi Li, et al.
Published: (2021-03-01)

Role of PFKFB3-driven glycolysis in sepsis
by: Min Xiao, et al.
Published: (2023-12-01)

PFKFB3: A Potential Key to Ocular Angiogenesis
by: Zi-Yi Zhou, et al.
Published: (2021-03-01)

Glycometabolic rearrangements--aerobic glycolysis in pancreatic cancer: causes, characteristics and clinical applications
by: Lidong Cao, et al.
Published: (2020-11-01)

PFKFB3 in neovascular eye disease: unraveling mechanisms and exploring therapeutic strategies
by: Peiyu Liu, et al.
Published: (2024-02-01)

The PFKFB3 Inhibitor AZ67 Inhibits Angiogenesis Independently of Glycolysis Inhibition
by: Besa Emini Veseli, et al.
Published: (2021-05-01)

Myeloid PFKFB3-mediated glycolysis promotes kidney fibrosis
by: Qiuhua Yang, et al.
Published: (2023-11-01)

Deficiency of Myeloid Pfkfb3 Protects Mice From Lung Edema and Cardiac Dysfunction in LPS-Induced Endotoxemia
by: Jiean Xu, et al.
Published: (2021-09-01)

PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent MannerSummary
by: Charles Shing Kam, et al.
Published: (2023-01-01)

PFKFB3-Mediated Glycolysis Boosts Fibroblast Activation and Subsequent Kidney Fibrosis
by: Qiuhua Yang, et al.
Published: (2023-08-01)

HSF1 promotes endometriosis development and glycolysis by up-regulating PFKFB3 expression
by: Yixin Wang, et al.
Published: (2021-06-01)

Anlotinib Inhibits PFKFB3-Driven Glycolysis in Myofibroblasts to Reverse Pulmonary Fibrosis
by: Weimou Chen, et al.
Published: (2021-09-01)

Inhibition of AMPK/PFKFB3 mediated glycolysis synergizes with penfluridol to suppress gallbladder cancer growth
by: Jiahao Hu, et al.
Published: (2022-07-01)

Positive regulation of PFKFB3 by PIM2 promotes glycolysis and paclitaxel resistance in breast cancer
by: Chao Lu, et al.
Published: (2021-04-01)

Identification of PFKFB2 as a key gene for the transition from acute to old myocardial infarction in peripheral blood
by: Xiangyu Yang, et al.
Published: (2022-12-01)

Increased stromal PFKFB3-mediated glycolysis in inflammatory bowel disease contributes to intestinal inflammation
by: Zhou Zhou, et al.
Published: (2022-11-01)

Overexpression of PFKFB3 promotes cell glycolysis and proliferation in renal cell carcinoma
by: Jun Li, et al.
Published: (2022-01-01)

KDM3A-mediated SP1 activates PFKFB4 transcription to promote aerobic glycolysis in osteosarcoma and augment tumor development
by: Wei Wang, et al.
Published: (2022-05-01)

Partial Inhibition of the 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase-3 (PFKFB3) Enzyme in Myeloid Cells Does Not Affect Atherosclerosis
by: Renée J. H. A. Tillie, et al.
Published: (2021-08-01)

Therapeutic targeting of PFKFB3 and PFKFB4 in multiple myeloma cells under hypoxic conditions
by: Seiichi Okabe, et al.
Published: (2022-05-01)

Targeting the SphK1/S1P/PFKFB3 axis suppresses hepatocellular carcinoma progression by disrupting glycolytic energy supply that drives tumor angiogenesis
by: Xin Tracy Liu, et al.
Published: (2024-01-01)

Additional dexamethasone in chemotherapies with carboplatin and paclitaxel could reduce the impaired glycometabolism in rat models
by: Yanxiu Guo, et al.
Published: (2018-01-01)

Glycometabolism-related gene signature of hepatocellular carcinoma predicts prognosis and guides immunotherapy
by: Lihua Yu, et al.
Published: (2022-07-01)

TRAF7 inhibits glycolysis to potentiate growth inhibition and apoptosis of myeloid leukemia cells via regulating the KLF2-PFKFB3 axis
by: Lin Zou, et al.
Published: (2023-06-01)

Effects of the Novel PFKFB3 Inhibitor KAN0438757 on Colorectal Cancer Cells and Its Systemic Toxicity Evaluation In Vivo
by: Tiago De Oliveira, et al.
Published: (2021-02-01)

Long noncoding RNA LINC00930 promotes PFKFB3-mediated tumor glycolysis and cell proliferation in nasopharyngeal carcinoma
by: Baoyu He, et al.
Published: (2022-02-01)

RORα inhibits gastric cancer proliferation through attenuating G6PD and PFKFB3 induced glycolytic activity
by: Xiaoshan Wang, et al.
Published: (2024-01-01)

Concentrations and association between exposure to mixed perfluoroalkyl and polyfluoroalkyl substances and glycometabolism among adolescents
by: Wu Yan, et al.
Published: (2023-12-01)

A glycometabolic gene signature associating with immune infiltration and chemosensitivity and predicting the prognosis of patients with osteosarcoma
by: Fengyan Wang, et al.
Published: (2023-05-01)

Microbiome Features Differentiating Unsupervised-Stratification-Based Clusters of Patients with Abnormal Glycometabolism
by: Ting Xu, et al.
Published: (2023-02-01)

Role of PFKFB3 and PFKFB4 in Cancer: Genetic Basis, Impact on Disease Development/Progression, and Potential as Therapeutic Targets
by: Krzysztof Kotowski, et al.
Published: (2021-02-01)

PFKFB3 downregulation aggravates Angiotensin II-induced podocyte detachment
by: Xiaoxiao Huang, et al.
Published: (2023-12-01)

Effect of admission glycometabolic state on clinical outcome in non diabetic subjects with acute st segment elevation myocardial infarction
by: Sameh Samir, et al.
Published: (2016-08-01)

Retinoic acid inhibits the angiogenesis of human embryonic stem cell-derived endothelial cells by activating FBP1-mediated gluconeogenesis
by: Zhuangzhuang Yang, et al.
Published: (2022-06-01)

Effect of PFKFB4 on the Prognosis and Immune Regulation of NSCLC and Its Mechanism
by: Zhou Y, et al.
Published: (2022-08-01)

The metabolic role of PFKFB4 in androgen-independent growth in vitro and PFKFB4 expression in human prostate cancer tissue
by: Ximing Li, et al.
Published: (2020-06-01)

Recognition of Glycometabolism-Associated lncRNAs as Prognosis Markers for Bladder Cancer by an Innovative Prediction Model
by: Dongdong Tang, et al.
Published: (2022-07-01)

Apelin-13 Attenuates Lipopolysaccharide-Induced Inflammatory Responses and Acute Lung Injury by Regulating PFKFB3-Driven Glycolysis Induced by NOX4-Dependent ROS
by: Yuan Y, et al.
Published: (2022-03-01)